Owner Actelion Pharmaceuticals Ltd

Inventors Meyer, Solange; Corminboeuf, Olivier; Binkert, Christoph; Grisostomi, Corinna; Boss, Christoph

Agent A J Park

Pub. Number AU-B-2006305538

PCT Pub. Number WO2007/046075

Priority PCT/ IB2005/053457 21.10.05 IB

Filing date 20 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 28 June 2012

C07D 295/18 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 209/04 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/16 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/26 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/38 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/40 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/60 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/74 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 217/04 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 217/14 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 233/54 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 239/42 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 277/28 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 307/14 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 317/58 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms